Peter Martin
Overview
Explore the profile of Peter Martin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
439
Citations
6638
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee Y, Gonzales E, Wu Y, Braun K, Martin P, Willcox B, et al.
J Alzheimers Dis Rep
. 2025 Mar;
8(1):1502-1515.
PMID: 40034359
Background: Despite the growing evidence on the modifiable and genetic factors associated with cognitive health, little is known about the role of the apolipoprotein E () gene ε4 allele in...
2.
Nastoupil L, Andersen C, Ayers A, Wang Y, Habermann T, Chihara D, et al.
Clin Lymphoma Myeloma Leuk
. 2025 Feb;
PMID: 39966020
Introduction: Clinical trials provide meaningful data regarding the safety and efficacy of novel therapies but there is often a lag between the time of new drug approval and information on...
3.
Luan D, Easwar N, Chen Z, Link B, Wang Y, Maurer M, et al.
Clin Lymphoma Myeloma Leuk
. 2025 Feb;
PMID: 39919998
Background: Survival in mantle cell lymphoma (MCL) has improved over time, with 1 potential reason being approval of new therapies. We hypothesized that access to multiple new agents with nonoverlapping...
4.
Yamshon S, Koff J, Larson M, Kahl B, Casulo C, Lossos I, et al.
Am J Hematol
. 2025 Feb;
100(4):606-615.
PMID: 39918101
Rituximab, gemcitabine, and oxaliplatin (R-GemOx) is a commonly used chemoimmunotherapy regimen for relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), but there are limited real-world data. In a multicenter...
5.
Cormie P, Bradford A, Doran C, Potts B, Martin P, Chiswell M, et al.
Support Care Cancer
. 2025 Jan;
33(2):77.
PMID: 39775110
Purpose: To evaluate cancer patients' willingness to pay for exercise services and oncology health professionals' perception of patients' willingness to pay. Methods: A mixed-methods design was used. Online questionnaires and...
6.
Chiong Hong S, Trinh T, Martin P, Chorny A, Moloney G
Cornea
. 2025 Jan;
PMID: 39774543
Osteo-odonto-keratoprosthesis (OOKP) is a surgical procedure reserved for severe end-stage corneal blindness with a dry, keratinized ocular surface. Late resorption of bone has been described as a complication of this...
7.
Swarbrick C, Williams K, Evans B, Blake H, Poulton T, Nava S, et al.
Br J Anaesth
. 2025 Jan;
134(2):328-340.
PMID: 39765405
Background: Frailty and multimorbidity are common in older adults, but the prevalence and interaction of these conditions in surgical patients remain unclear. This study describes the clinical characteristics of a...
8.
Isshiki Y, Chen X, Teater M, Karagiannidis I, Nam H, Cai W, et al.
Cancer Cell
. 2024 Dec;
43(1):49-68.e9.
PMID: 39642889
T cell-based immunotherapies have demonstrated effectiveness in treating diffuse large B cell lymphoma (DLBCL) and follicular lymphoma (FL) but predicting response and understanding resistance remains a challenge. To address this,...
9.
Day J, Larson M, Durani U, Koff J, Wang Y, Habermann T, et al.
Blood Adv
. 2024 Nov;
9(5):1013-1023.
PMID: 39602301
Progression of disease within 24 months of initial immunochemotherapy (POD24) is a negative prognostic factor for patients with follicular lymphoma (FL). There is no standard treatment after POD24. Assembling an...
10.
Kikuchi A, Martin P, Gondo Y
Int J Aging Hum Dev
. 2024 Nov;
:914150241297521.
PMID: 39533903
This study aims to test the hypothesis that the association between aging anxiety and ageism will be enhanced by age differently in the United States and in Japan. Data were...